MeSH term
Frequency | Condition_Probility | Animals | 31 | 0.0 |
Cell Line | 11 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Humans | 88 | 0.0 |
Rabbits | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 52 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 27 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Biological Markers | 2 | 0.0 |
Calcium/blood | 2 | 0.0 |
Receptors, Calcium-Sensing/*physiology | 2 | 40.0 |
Biological Transport/physiology | 2 | 1.0 |
In Vitro | 2 | 0.0 |
Male | 35 | 0.0 |
Rats | 13 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Receptors, Calcium-Sensing | 50 | 75.0 |
Receptors, Cell Surface/*physiology | 5 | 2.0 |
Aged | 13 | 0.0 |
Alleles | 5 | 0.0 |
Analysis of Variance | 4 | 0.0 |
Bone Density/*genetics | 3 | 2.0 |
Calcium/*metabolism | 11 | 1.0 |
Cohort Studies | 2 | 0.0 |
Comparative Study | 4 | 0.0 |
Female | 38 | 0.0 |
Genotype | 11 | 0.0 |
Lumbar Vertebrae/physiology | 2 | 15.0 |
Middle Aged | 26 | 0.0 |
Polymorphism, Genetic/*genetics | 3 | 0.0 |
Receptors, Cell Surface/*genetics | 19 | 6.0 |
Adolescent | 11 | 0.0 |
Adult | 28 | 0.0 |
Age Factors | 2 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Alternative Splicing | 3 | 0.0 |
Base Sequence | 12 | 0.0 |
Calcitriol/*pharmacology | 3 | 1.0 |
Mice | 9 | 0.0 |
Molecular Sequence Data | 12 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Protein p53/metabolism | 2 | 0.0 |
Receptors, Cell Surface/metabolism | 3 | 0.0 |
Calcium/metabolism | 10 | 0.0 |
Child | 11 | 0.0 |
Gene Frequency | 6 | 0.0 |
Japan | 3 | 0.0 |
*Polymorphism, Genetic | 4 | 0.0 |
Receptors, Calcitriol/genetics | 2 | 4.0 |
Receptors, Estrogen/genetics | 2 | 3.0 |
Calcium/*blood | 3 | 3.0 |
English Abstract | 6 | 0.0 |
Predictive Value of Tests | 3 | 0.0 |
Prognosis | 2 | 0.0 |
Receptors, Calcium-Sensing/*genetics | 3 | 75.0 |
Mutation | 9 | 0.0 |
Calcium/*urine | 7 | 21.0 |
Hypercalcemia/*genetics | 2 | 40.0 |
Hyperparathyroidism/*genetics | 4 | 10.0 |
Infant, Newborn | 12 | 0.0 |
Blotting, Western | 6 | 0.0 |
Immunohistochemistry | 9 | 0.0 |
Parathyroid Glands/*metabolism | 2 | 20.0 |
Receptors, Calcitriol/metabolism | 2 | 3.0 |
DNA Mutational Analysis | 6 | 0.0 |
Hyperplasia | 3 | 0.0 |
Polymerase Chain Reaction | 8 | 0.0 |
Receptors, Cell Surface/*genetics/metabolism | 4 | 4.0 |
Exons/genetics | 2 | 0.0 |
Infant | 2 | 0.0 |
Mutation/*genetics | 3 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 8 | 0.0 |
Autoantibodies/*blood | 2 | 0.0 |
Immunoblotting | 3 | 0.0 |
Receptors, Calcium-Sensing/*immunology | 2 | 100.0 |
Amino Acid Sequence | 5 | 0.0 |
Heterozygote | 4 | 0.0 |
Homozygote | 5 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Organ Specificity | 3 | 0.0 |
Phenotype | 4 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
*Genes, Dominant | 3 | 1.0 |
*Mutation | 4 | 0.0 |
Pedigree | 10 | 0.0 |
Sequence Analysis, DNA | 7 | 0.0 |
*Bone Density | 2 | 1.0 |
Parathyroid Hormone/blood | 4 | 2.0 |
Inositol Phosphates/biosynthesis | 2 | 8.0 |
Magnesium/metabolism | 3 | 4.0 |
Hypercalcemia/complications/genetics | 2 | 100.0 |
*Mutation, Missense | 2 | 0.0 |
Cell Division | 2 | 0.0 |
Receptors, Cell Surface/*metabolism | 2 | 0.0 |
Reference Values | 2 | 0.0 |
Adenoma/*metabolism | 3 | 5.0 |
Aged, 80 and over | 5 | 0.0 |
Parathyroid Glands/chemistry | 2 | 66.0 |
Parathyroid Neoplasms/*metabolism | 2 | 50.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Genetic Markers | 2 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Hypocalcemia/*genetics | 3 | 75.0 |
Transfection | 5 | 0.0 |
Cells, Cultured | 6 | 0.0 |
Parathyroid Hormone/metabolism | 3 | 15.0 |
Cloning, Molecular | 4 | 0.0 |
Gene Expression | 3 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Homeostasis | 6 | 1.0 |
Receptors, Calcium-Sensing/genetics | 2 | 66.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Gadolinium/pharmacology | 4 | 40.0 |
Gene Expression/physiology | 2 | 0.0 |
Neomycin/pharmacology | 2 | 10.0 |
Genes, Dominant | 6 | 0.0 |
Chromosomes, Human, Pair 3 | 2 | 1.0 |
Kidney/*metabolism | 2 | 1.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Receptors, Calcium-Sensing/*metabolism | 2 | 66.0 |
Signal Transduction/physiology | 3 | 0.0 |
Calcium/*pharmacology | 2 | 2.0 |
Codon | 2 | 0.0 |
Hypercalcemia/genetics | 2 | 66.0 |
Parathyroid Hormone/secretion | 4 | 33.0 |
Glycosylation | 2 | 0.0 |
Hypercalcemia/*genetics/*metabolism | 2 | 100.0 |
Hyperparathyroidism/*genetics/*metabolism | 2 | 66.0 |
Cattle | 2 | 0.0 |
Models, Molecular | 4 | 0.0 |
Point Mutation | 2 | 0.0 |
Receptors, Cell Surface/chemistry/*physiology | 2 | 14.0 |
Child, Preschool | 3 | 0.0 |
Parathyroid Glands/pathology | 3 | 21.0 |
DNA, Complementary | 2 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
Binding Sites | 2 | 0.0 |
HLA-DR Antigens/genetics | 2 | 0.0 |
Haplotypes | 2 | 0.0 |
Ki-67 Antigen/analysis | 2 | 0.0 |
Extracellular Fluid/metabolism | 2 | 33.0 |
Receptors, Calcium-Sensing/*agonists | 2 | 100.0 |
Receptors, Calcium-Sensing/*genetics/metabolism | 2 | 100.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Receptors, Calcium-Sensing/genetics/*metabolism | 2 | 100.0 |
Receptors, Cell Surface/*genetics/*metabolism | 3 | 21.0 |
Oligonucleotide Probes | 2 | 0.0 |
